SCHEMBL376325

SCHEMBL376325

CCCOC(=O)CCCCC(=O)OCCO

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.63
MGLL Q99685 1/20 0.57
DNM1 Q05193 1/20 0.52
PAM P19021 2/20 0.47
KDM4E B2RXH2 1/20 0.46
DUSP3 P51452 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
LMNA P02545 1/20 0.46
ACHE P22303 1/20 0.46
PRSS1 P07477 1/20 0.45
PRSS2 P07478 1/20 0.45
PRSS3 P35030 1/20 0.45
EPHX2 P34913 2/20 0.44
ALDH1A1 P00352 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TSHR P16473 1/20 0.44
MAPT P10636 1/20 0.44
PRKCA P17252 1/20 0.43
PRKCE Q02156 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3503110 0.91 DGKA (0.63) DGKAMGLLDNM1PAMKDM4E
SCHEMBL117775 0.91 DGKA (0.76) DGKAMGLLDNM1PAMKDM4E
SCHEMBL6363267 0.91 MGLL (0.51) DGKAMGLLDNM1LMNAACHE
SCHEMBL33810 0.91 DGKA (0.74) DGKADNM1PAMKDM4EDUSP3
SCHEMBL23656812 0.89 DGKA (0.80) DGKAMGLLDNM1PAMKDM4E
SCHEMBL3503192 0.89 DGKA (0.80) DGKAMGLLDNM1PAMKDM4E
SCHEMBL1443883 0.89 DGKA (0.80) DGKAMGLLDNM1PAMKDM4E
SCHEMBL406849 0.89 DGKA (0.80) DGKAMGLLDNM1PAMKDM4E
SCHEMBL825306 0.89 DGKA (0.80) DGKAMGLLDNM1PAMKDM4E
SCHEMBL168967 0.89 DGKA (0.80) DGKAMGLLDNM1PAMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230374249-A1 TEREPHTHALIC ACID ESTERS FORMATION 9449710 CANADA INC. (CA) 2023-11-23 US disclosed
US-20230125080-A1 TEREPHTHALIC ACID ESTERS FORMATION 9449710 CANADA INC. (CA) 2023-04-27 US disclosed
EP-2408831-B2 THERMOPLASTIC POLYURETHANE WITH REDUCED TENDENCY TO BLOOM LUBRIZOL ADVANCED MAT INC (US) 2020-03-04 EP disclosed
EP-3415542-A1 PROCESS OF MAKING A THERMOPLASTIC POLYURETHANE WITH REDUCED TENDENCY TO BLOOM Lubrizol Advanced Materials, Inc. (US) 2018-12-19 EP disclosed
EP-3199563-B1 PROCESS OF MAKING A THERMOPLASTIC POLYURETHANE WITH REDUCED TENDENCY TO BLOOM LUBRIZOL ADVANCED MAT INC (US) 2018-09-19 EP disclosed
EP-3199563-A1 PROCESS OF MAKING A THERMOPLASTIC POLYURETHANE WITH REDUCED TENDENCY TO BLOOM Lubrizol Advanced Materials, Inc. (US) 2017-08-02 EP disclosed
EP-2408831-B1 THERMOPLASTIC POLYURETHANE WITH REDUCED TENDENCY TO BLOOM LUBRIZOL ADVANCED MAT INC (US) 2017-05-10 EP disclosed
US-20160347900-A1 SOFTENING THERMOPLASTIC POLYURETHANES USING IONOMER TECHNOLOGY THE UNIVERSITY OF AKRON 2016-12-01 US disclosed
US-9403303-B2 Thermoplastic polyurethane with reduced tendency to bloom LUBRIZOL ADVANCED MATERIALS, INC. (US) 2016-08-02 US disclosed
US-20140333001-A1 Thermoplastic Polyurethane With Reduced Tendency To Bloom LUBRIZOL ADVANCED MATERIALS, INC. 2014-11-13 US disclosed
US-8790763-B2 Thermoplastic polyurethane with reduced tendency to bloom LUBRIZOL ADVANCED MATERIALS, INC. (US) 2014-07-29 US disclosed
EP-2721082-A1 THERMOPLASTIC POLYURETHANE WITH REDUCED TENDENCY TO BLOOM FROM A BIO-BASED GLYCOL Lubrizol Advanced Materials, Inc. (US) 2014-04-23 EP disclosed
WO-2012173911-A1 THERMOPLASTIC POLYURETHANE WITH REDUCED TENDENCY TO BLOOM FROM A BIO-BASED GLYCOL LUBRIZOL ADVANCED MATERIALS, INC. (US) 2012-12-20 WO disclosed
EP-2408831-A1 THERMOPLASTIC POLYURETHANE WITH REDUCED TENDENCY TO BLOOM Lubrizol Advanced Materials, Inc. (US) 2012-01-25 EP disclosed
US-20100239803-A1 Thermoplastic Polyurethane With Reduced Tendency To Bloom LUBRIZOL ADVANCED MATERIALS, INC. (US) 2010-09-23 US disclosed
WO-2010107562-A1 THERMOPLASTIC POLYURETHANE WITH REDUCED TENDENCY TO BLOOM LUBRIZOL ADVANCED MATERIALS, INC. (US) 2010-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230125080-A1 TEREPHTHALIC ACID ESTERS FORMATION DGAT2, TKT, SLC16A3 DGKA 129/4885MGLL 291/4885DNM1 2546/4885
US-20230374249-A1 TEREPHTHALIC ACID ESTERS FORMATION DGAT2, DGAT1, SLC16A3 DGKA 120/4885MGLL 241/4885DNM1 2175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.